2-Hydroxybenzimidazole

CAS No. 615-16-7

2-Hydroxybenzimidazole( —— )

Catalog No. M15321 CAS No. 615-16-7

2-Hydroxybenzimidazole is used as an intermediate in industry.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 45 In Stock
25MG 61 In Stock
50MG 98 In Stock
100MG 129 In Stock
200MG 181 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-Hydroxybenzimidazole
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Hydroxybenzimidazole is used as an intermediate in industry.
  • Description
    2-Hydroxybenzimidazole is used as an intermediate in industry.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    615-16-7
  • Formula Weight
    134.14
  • Molecular Formula
    C7H6N2O
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    O=C1NC2=CC=CC=C2N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.O?retir C, et al. J Mol Model. 2003 Dec;9(6):390-4.
molnova catalog
related products
  • Acetyl shikonin

    Acetylshikonin exhibits weak cytotoxicity against human umbilical vein endothelial cells (HUVECs) with IC5 of over 2 microM, exhibits the antiangiogenic and antitumorigenic effects by suppressing proliferation and angiogenic factors.

  • Ilexoside XLVIII

    Ilexoside XLVIII is an acyl CoA cholesteryl acyl transferase ( ACAT ) inhibitor. Ilexoside XLVIII is a triterpene saponin isolated from an aqueous extract of the leaves of Ilex kudincha.

  • PIN1 inhibitor API-1

    PIN1 inhibitor API-1 is a specific Pin1 inhibitor (IC50: 72.3 nM). PIN1 inhibitor API-1 retains the active conformation of pXPO5 and restores the ability of pXPO5 to transport pre-miRNAs from the nucleus to cytoplasm, thus up-regulating the anticancer miRNA biogenesis to suppress both in vitro and in vivo hepatocellular carcinoma development.